Head-to-head comparison of anterior nares and nasopharyngeal swabs for SARS-CoV-2 antigen detection in a community drive-through test centre in the UK

被引:0
作者
Byrne, Rachel L. [1 ]
Aljayyoussi, Ghaith [1 ]
Kontogianni, Konstantina [1 ]
Clerkin, Karina [1 ]
Mcintyre, Mathew [1 ]
Wardale, Jahanara [1 ]
Williams, Christopher T. [1 ]
Body, Richard [2 ]
Adams, Emily R. [3 ,4 ]
de Vos, Margaretha [5 ]
Escadafal, Camille [5 ]
Atienzar, Ana I. Cubas [1 ]
机构
[1] Univ Liverpool Liverpool Sch Trop Med, Ctr Drugs & Diagnost, Liverpool, England
[2] Manchester Univ NHS Fdn Trust, Manchester, England
[3] Global Access Diagnost GADx, Thurleigh, England
[4] Univ Oxford, Nuffield Dept Med, Oxford, England
[5] FIND, Geneva, Switzerland
关键词
COVID-19;
D O I
10.1136/bmjresp-2023-001747
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective To conduct a head-to-head diagnostic accuracy evaluation of anterior nares (AN) and nasopharyngeal (NP) swabs for SARS-CoV-2 antigen detection using two brands of rapid diagnostic tests (Ag-RDT).Methods Two prospective diagnostic evaluations were carried out at different time points and participant cohorts to evaluate the performance of paired AN and NP swabs in two Ag-RDT brands: Sure-Status (PMC, India) and Biocredit (RapiGEN, South Korea). The sensitivity and specificity of AN and NP swabs for each of the index test cohorts were calculated against the reverse transcription quantitative PCR (RT-qPCR) TaqPath COVID-19 (ThermoFisher, UK) using NP swabs as reference standard.Results A total of 372 participants were recruited for the Sure-Status cohort and 232 for the Biocredit, of which 119 (32.1%) and 122 (53.7%) were SARS-CoV-2 positive by RT-qPCR, respectively. Sensitivity and specificity of AN swabs were equivalent to those obtained with NP swabs in both cohorts: 83.9% (95% CI 76.0-90.0) and 98.8% (95% CI 96.6-9.8) using NP swabs and 85.6% (95% CI 77.1-91.4) and 99.2% (95% CI 97.1-99.9) with AN swabs for Sure-Status and; 81.2% (95% CI 73.1-87.7) and 99.0% (95% CI 94.7-86.5) with NP swabs and 79.5% (95% CI 71.3-86.3) and 100% (95% CI 96.5-100) with AN swabs for Biocredit. The agreement of the AN and NP swabs was high for both brands with an inter-rater reliability (kappa) of 0.918 and 0.833 for Sure-Status and Biocredit, respectively. The overall 50% limits of detection (LoD50) and 95% LoD (LoD95) were 0.9-2.4x104 and 3.0-3.2x108 RNA copies/mL for NP swabs and 0.3-1.1x105 and 0.7-7.9x107 RNA copies/mL for AN swabs, with no significant difference in LoD for any of the swab types or test brands.Conclusions The diagnostic accuracy of the two SARS-CoV-2 Ag-RDT brands evaluated in this study was equivalent using AN swabs than NP swabs. However, test line intensity was lower when using AN swabs, which could negatively influence the interpretation of the Ag-RDT results by lay users.Trail registration number NCT04408170.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Head-to-Head Comparison of Nasopharyngeal, Oropharyngeal and Nasal Swabs for SARS-CoV-2 Molecular Testing
    Larsen, Kasper Daugaard
    Jensen, Mads Mose
    Homoe, Anne-Sophie
    Arndal, Elisabeth
    Samuelsen, Grethe Badsberg
    Koch, Anders
    Nielsen, Xiaohui Chen
    Homoe, Preben
    Todsen, Tobias
    DIAGNOSTICS, 2023, 13 (02)
  • [2] Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection
    Favresse, Julien
    Gillot, Constant
    Oliveira, Maxime
    Cadrobbi, Julie
    Elsen, Marc
    Eucher, Christine
    Laffineur, Kim
    Rosseels, Catherine
    Van Eeckhoudt, Sandrine
    Nicolas, Jean-Baptiste
    Morimont, Laure
    Dogne, Jean-Michel
    Douxfils, Jonathan
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (02) : 1 - 10
  • [3] Detection of SARS-CoV-2 in Nasal Swabs: comparison with Nasopharyngeal Swabs
    Kim, Hyun Ah
    Hyun, Miri
    Lee, Ji Yeon
    Park, Sunggyun
    Ryoo, Namhee
    Kwon, Yong Shik
    Park, Jae Seok
    Kim, Jin Young
    Jeon, Jae Cheon
    Peck, Kyong Ran
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2020, 14 (10): : 1081 - 1083
  • [4] Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays
    Merrill, Anna E.
    Jackson, J. Brooks
    Ehlers, Alexandra
    Voss, Dena
    Krasowski, Matthew D.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2020, 5 (06) : 1351 - 1357
  • [5] Rapid antigen test as a screening tool for SARS-CoV-2 infection: Head-to-head comparison with qRT-PCR in Ethiopia
    Gobena, Dabesa
    Gudina, Esayas Kebede
    Gebre, Getu
    Degfie, Tizta Tilahun
    Mekonnen, Zeleke
    HELIYON, 2024, 10 (01)
  • [6] Comparison of Throat Washings, Nasopharyngeal Swabs and Oropharyngeal Swabs for Detection of SARS-CoV-2
    Hitzenbichler, Florian
    Bauernfeind, Stilla
    Salzberger, Bernd
    Schmidt, Barbara
    Wenzel, Juergen J.
    VIRUSES-BASEL, 2021, 13 (04):
  • [7] Evaluation of the Elecsys SARS-CoV-2 antigen assay for the detection of SARS-CoV-2 in nasopharyngeal swabs.
    Ben Abdelhanin, Myriam
    Mvumbi, Dieudonne M.
    Agathine, Aurelie
    Nanos, Nikolaos
    Gidenne, Stephane
    JOURNAL OF CLINICAL VIROLOGY, 2021, 144
  • [8] Exploring alternative swabs for use in SARS-CoV-2 detection from the oropharynx and anterior nares
    Patriquin, Glenn
    Davis, Ian
    Heinstein, Charles
    MacDonald, Jimmy
    Hatchette, Todd F.
    LeBlanc, Jason J.
    JOURNAL OF VIROLOGICAL METHODS, 2020, 285
  • [9] Evaluation of PCL rapid point of care antigen test for detection of SARS-CoV-2 in nasopharyngeal swabs
    Rastawicki, Waldemar
    Gierczynski, Rafal
    Juszczyk, Grzegorz
    Mitura, Kryspin
    Henry, Brandon Michael
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) : 1920 - 1922
  • [10] Comparison of BinaxNOW and SARS-CoV-2 qRT-PCR Detection of the Omicron Variant from Matched Anterior Nares Swabs
    Landaverde, Lena
    Turcinovic, Jacquelyn
    Doucette-Stamm, Lynn
    Gonzales, Kevin
    Platt, Judy
    Connor, John H.
    Klapperich, Catherine
    MICROBIOLOGY SPECTRUM, 2022, 10 (06):